Objectives: Expanding medication abortion to the pharmacy setting could help women access safe care. Studies have not evaluated pharmacy interventions. This non-inferiority study in Nepal investigated whether mifepristone-misoprostol medication abortion provided by trained nurses from pharmacies could be as effective and safe as when provided from government-certified abortion facilities. Methods: Nurses in two districts, Chitwan ...Read more >

Objectives: To gain training and expertise in bioethics to inform scholarship and further ongoing bioethical research about Catholic hospital obstetric care. To develop a bioethical framework regarding restrictions on reproductive health care in religious hospitals to inform a sociological crossover book about Catholic health care in the US. Methods: Training was gained through an intensive ...Read more >

With expanded access to affordable antiretroviral therapy (ART) in sub-Saharan Africa and the recommendation of earlier thresholds for treatment initiation, HIV-infected women are living longer, healthier lives. For HIV-infected women taking ART, using modern methods of contraception to plan pregnancy when CD4 count is high and viral load is low benefits maternal health and prevents ...Read more >

Over a thousand reproductive-aged, homeless women live in San Francisco, many of whom actively use substances. These women often exclusively contact the healthcare system through substance use treatment programs, and/or street-based homeless services. These women also frequently present to labor and delivery with scant prenatal care, or to the Women’s Options Center for later abortions ...Read more >

Approximately 100,000 abortions occur annually in Canada, of which 96% have been provided using surgery to date. Mifepristone, the gold standard for medical abortion, was made available for the first time in Canada in January 2017. The availability of mifepristone has particular potential to improve care for women in rural and remote communities, who currently ...Read more >

Background and significance: The opioid epidemic is a public health crisis affecting the lives of a large number of reproductive age women in the US. Women who use opioids have high rates of unintended pregnancy, low contraceptive use, and they experience social stigma that puts them at risk for low-quality and disrespectful health care. Despite ...Read more >

Over the past decade, our team has worked with families to develop interventions to improve how parents communicate with adolescents about sexual health issues. In recent years, parents have increasingly asked that content be delivered online. Parents report that as families’ schedules have become busier, it is difficult to attend in-person programs. Parents want a ...Read more >

There is longstanding recognition of the limitations of current approaches to conceptualizing and measuring pregnancy intentions. Foundationally, the concept of planning a pregnancy may not be relevant to many women, including women of color, poor women, and young women – the groups considered at greatest risk of unintended pregnancy. Our qualitative research has revealed that ...Read more >

Background: Laws mandating parental consent or notification for minors seeking abortion currently affect girls in 38 states. Over the last three years, legislators proposed over 90 measures to introduce new or strengthen existing laws in 27 states. Despite their prevalence, parental involvement laws’ effects on girls’ access to and experience of abortion remain poorly described, ...Read more >

Depot medroxyprogesterone acetate (DMPA) is a progestin-only, hormonal contraceptive that is extremely effective, obviates the need for daily or weekly compliance, and can be used privately. DMPA is very appealing for the adolescent contraceptive user. Despite its many advantages, DMPA continuation rates are low in adolescents. Side effects, namely weight gain and bone mineral density ...Read more >